Login / Signup

Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study.

Luis Fernando Valladales-RestrepoMaría Camila Oyuela-GutiérrezAna Camila Delgado-AraujoJorge Enrique Machado-Alba
Published in: Pharmaceuticals (Basel, Switzerland) (2023)
The pharmacological treatment of glaucoma was very heterogeneous, but the most commonly used therapeutic groups were in accordance with the recommendations of clinical practice guidelines but with differences by sex and age. Most of the patients were exposed to preservatives, especially benzalkonium chloride, but the wide use of FDC drugs can minimize toxicity on the ocular surface.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • oxidative stress
  • prognostic factors
  • risk factors
  • clinical practice
  • optical coherence tomography
  • patient reported outcomes